Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 1:27 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1033–1056 of 2,752 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: High Activity Clear all

Conditions: Fibromyalgia (FM)
Interventions: Primary Motor Cortex Stimulation, Occipital Lobe Stimulation; Device
Lead sponsor: Pulkit Grover; Other
Eligibility: 18 Years to 65 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 2
States / cities: Pittsburgh, Pennsylvania

Conditions: Pneumonitis, SARS-CoV Infection
Interventions: GLS-1027, Placebo; Drug
Lead sponsor: GeneOne Life Science, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: Drug Abuse
Interventions: brief intervention (cognitive-behavioral therapy); Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 13 Years to 19 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Low Back Pain
Interventions: HVLA-SM, LVVA-SM, Usual Medical Care; Other
Lead sponsor: Palmer College of Chiropractic; Other
Eligibility: 21 Years to 55 Years
Enrollment: 192 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Davenport, Iowa

Conditions: Patients With Drug-resistant Focal Epilepsy, SEEG as Part of Presurgical Evaluation
Interventions: Direct Electric Stimulation (DES); Other
Lead sponsor: Hospices Civils de Lyon; Other
Eligibility: 18 Years to 55 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Anxiety, Cognitive Behavioral Therapy, Mechanical Ventilation Complication
Interventions: Cognitive Behavioral Therapy; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: Up to 100 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Obesity, Visceral, Cardiovascular Diseases, Fat Disorder
Interventions: Liraglutide, Placebo; Drug
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 35 Years and older
Enrollment: 235 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Metabolic Disorders, Physical Inactivity, Vascular Disease Risk
Interventions: reduced physical activity; Other
Lead sponsor: Miami University; Other
Eligibility: 18 Years to 40 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Oxford, Ohio

Conditions: Rheumatoid Arthritis
Interventions: GDC-0853, Adalimumab, Folic Acid, MTX, Placebo; Drug
Lead sponsor: Genentech, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 578 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 23
States / cities: Anniston, Alabama • Glendale, Arizona • Covina, California + 18 more

Conditions: Pediatric Obesity, Implementation
Interventions: Fit Together, Educational materials; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 5 Years to 12 Years
Enrollment: 209 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 3
States / cities: Charlotte, North Carolina • Durham, North Carolina • Winston-Salem, North Carolina

Conditions: Pain, Virtual Reality, Placebo, Temporomandibular Disorder
Interventions: RelieVRx, Sham-VR, No-VR (natural history control); Device · Other
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years to 88 Years
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Baltimore, Maryland

Conditions: Parenting Intervention
Interventions: Singing intervention, Music listening intervention, Book reading intervention; Behavioral
Lead sponsor: Yale University; Other
Eligibility: Not listed
Enrollment: 216 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Hypertriglyceridemia
Interventions: DHA-rich fish oil versus Phospholipid-rich fish oil; Dietary Supplement
Lead sponsor: Arctic Nutrition AS; Industry
Eligibility: 18 Years to 59 Years
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 1
States / cities: Addison, Illinois

Conditions: Hypogonadism
Interventions: TSX-002; Drug
Lead sponsor: TesoRx Pharma, LLC; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Parkinson Disease
Interventions: High-Intensity Aerobic Exercise (AE), Usual and Customary Care (UCC); Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 256 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 2
States / cities: Cleveland, Ohio • Salt Lake City, Utah

Conditions: Myofascial Pain Syndrome, Healthy
Interventions: Ultrasound imaging, Bioimpedance spectroscopy, Electromyography, Physical examination; Diagnostic Test
Lead sponsor: George Mason University; Other
Eligibility: 18 Years and older
Enrollment: 96 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Fairfax, Virginia

Conditions: Misophonia, Emotion Dysregulation, Sensory Processing Disorder, Auditory Over Responsivity, Anxiety Disorder, Sound Sensitivity
Interventions: High Frequency Repetitive Transcranial Magnetic Stimulation (HF rTMS), Sham Repetitive Transcranial Magnetic Stimulation (sham- rTMS), Cognitive Restructuring; Device · Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 55 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Hypertension
Interventions: Technology-enabled Team Care, Enhanced Usual Care; Other
Lead sponsor: East Carolina University; Other
Eligibility: 19 Years and older
Enrollment: 780 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2029
U.S. locations: 2
States / cities: Greenville, North Carolina • Wilmington, North Carolina

Conditions: Metabolism
Interventions: 4 hours of physical inactivity, 8 hours of physical inactivity, 12 hours of physical inactivity; Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 40 Years
Enrollment: 8 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Austin, Texas

Conditions: GHD
Interventions: GenSci004, Genotropin; Drug
Lead sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.; Industry
Eligibility: 3 Years to 12 Years
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Hypertension
Interventions: Spinal Manipulation, Sham Spinal Manipulation; Other
Lead sponsor: Palmer College of Chiropractic; Other
Eligibility: 21 Years to 75 Years
Enrollment: 51 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Davenport, Iowa

Conditions: Adenovirus
Interventions: Brincidofovir, Standard of Care; Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 18 Years to 99 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 4
States / cities: Los Angeles, California • Chicago, Illinois • Boston, Massachusetts + 1 more

Conditions: Chemo-brain, Chemotherapy-Related Cognitive Impairment
Interventions: Neuroplasticity-based Computerized Cognitive Remediation, Active Control Condition; Behavioral
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 35 Years to 80 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2030
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Stargardt Disease, Stargardt Macular Degeneration, Stargardt Macular Dystrophy
Interventions: SB-007; Genetic
Lead sponsor: Splice Bio; Industry
Eligibility: 12 Years to 65 Years
Enrollment: 57 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 5
States / cities: Aurora, Colorado • Miami, Florida • Boston, Massachusetts + 2 more

Search by objective public record fields.

Feasibility and Effects of Noninvasive Brain Stimulation on Pain Perception in People With Fibromyalgia

GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)

Brief Intervention for Drug Abusing Adolescents

Predicting Patients' Response to Spinal Manipulation

Links Between Epileptic Activity, Sleep Disruption and Mental Content During Sleep

Cognitive Behavioral Therapy for Mechanical Ventilation Wean

Impact of Liraglutide 3.0 on Body Fat Distribution

Interactive Roles of Cardiorespiratory Fitness and Adiposity on Glucose and Vascular Control After Physical Inactivity

Safety and Efficacy Study of GDC-0853 Compared With Placebo and Adalimumab in Participants With Rheumatoid Arthritis (RA)

Parks & Pediatrics Fit Together

Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG)

Effects of Enriched Parent-Infant Interaction on Health in Early Life

Bioavailability of EPA and DHA From Two Dietary Supplements

Oral Testosterone for the Treatment of Hypogonadism

Pragmatic Cyclical Lower Extremity Exercise Trial for Parkinson's Disease

Imaging Biomarkers for Myofascial Pain

Using Neurostimulation to Accelerate Change in Misophonia: a Pilot Study

Heart to Heart: BP Control Partners

Duration of Physical Inactivity and Postprandial Lipid Metabolism

A Study to Investigate Efficacy and Safety of Weekly PEG-somatropin (GenSci004) in Treatment Naive Children With Growth Hormone Deficiency

Chiropractic for Hypertension in Patients

Open Label Study of IV Brincidofovir in Adult Transplant Recipients With Adenovirus Viremia

nCCR for Chemotherapy Related Cognitive Impairment Randomized Study

A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)